Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11160351rdf:typepubmed:Citationlld:pubmed
pubmed-article:11160351lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11160351lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:11160351lifeskim:mentionsumls-concept:C0085243lld:lifeskim
pubmed-article:11160351lifeskim:mentionsumls-concept:C0011854lld:lifeskim
pubmed-article:11160351lifeskim:mentionsumls-concept:C0927232lld:lifeskim
pubmed-article:11160351lifeskim:mentionsumls-concept:C0004359lld:lifeskim
pubmed-article:11160351lifeskim:mentionsumls-concept:C0393639lld:lifeskim
pubmed-article:11160351lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:11160351pubmed:issue4lld:pubmed
pubmed-article:11160351pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11160351pubmed:abstractTextType I diabetes and multiple sclerosis (MS) are distinct autoimmune diseases where T cells target either islet or CNS self-proteins. Unexpectedly, we found that autoreactive T cells in diabetic patients, relatives with high diabetes risk, nonobese diabetic (NOD) mice, and MS patients routinely target classical islet as well as CNS autoantigens. The pathogenic potential of CNS autoreactivity was testable in NOD mice. Pertussis holotoxin, without additional Ags or adjuvants, allowed development of an NOD mouse-specific, autoimmune encephalitis with variable primary-progressive, monophasic, and relapsing-remitting courses. T cells from diabetic donors transferred CNS disease to pertussis toxin-pretreated NOD.scid mice, with accumulation of CD3/IFN-gamma transcripts in the brain. Diabetes and MS appear more closely related than previously perceived. NOD mouse-specific, autoimmune encephalitis provides a new MS model to identify factors that determine alternative disease outcomes in hosts with similar autoreactive T cell repertoires.lld:pubmed
pubmed-article:11160351pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160351pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160351pubmed:languageenglld:pubmed
pubmed-article:11160351pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160351pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11160351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11160351pubmed:statusMEDLINElld:pubmed
pubmed-article:11160351pubmed:monthFeblld:pubmed
pubmed-article:11160351pubmed:issn0022-1767lld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:DoschH MHMlld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:MoscarelloMMlld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:CheungRRlld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:BeckerD JDJlld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:KubiakVVlld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:O'ConnorP WPWlld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:McKerlieCClld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:CortezM AMAlld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:WinerSSlld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:GunaratnamLLlld:pubmed
pubmed-article:11160351pubmed:authorpubmed-author:AstsaturovIIlld:pubmed
pubmed-article:11160351pubmed:issnTypePrintlld:pubmed
pubmed-article:11160351pubmed:day15lld:pubmed
pubmed-article:11160351pubmed:volume166lld:pubmed
pubmed-article:11160351pubmed:ownerNLMlld:pubmed
pubmed-article:11160351pubmed:authorsCompleteYlld:pubmed
pubmed-article:11160351pubmed:pagination2831-41lld:pubmed
pubmed-article:11160351pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:meshHeadingpubmed-meshheading:11160351...lld:pubmed
pubmed-article:11160351pubmed:year2001lld:pubmed
pubmed-article:11160351pubmed:articleTitleType I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis.lld:pubmed
pubmed-article:11160351pubmed:affiliationThe Hospital For Sick Children, St. Michael's Hospital, University of Toronto, Sunnybrook and Women's College Health Sciences Center, University of Toronto, Ontario, Canada.lld:pubmed
pubmed-article:11160351pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11160351pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11160351pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11160351pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160351lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160351lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160351lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160351lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160351lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11160351lld:pubmed